Question follow-through · 32740
Drugs and Medical Equipment: Research
To ask the Secretary of State for Health and Social Care, if he will make an (a) economic and (b) regulatory assessment of the potential impact of In Silico computer modelling and simulation methods on the (i) pharmaceutical and (ii) medical device sector
About this written question
A written question asks a government minister for information in writing. Parliament publishes the question and any answer.
- Answering body
- Department of Health and Social Care
- Tabled
- 21 Feb 2025
- Target answer date
- 25 Feb 2025
- Answer
- 12 Mar 2025 · 19 calendar days after tabling
Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.
More questions by this MP on Economy and business
- ME/CFS · 20 Mar 2025
Shared topic keywords suggest a connection; they do not establish a follow-up.
Votes on this topic
- Draft Code of Practice on Electronic and Workplace Ballots for Statutory Trade Union Ballots · 15 Jul 2026
- Draft Trade Unions (Permissible Means of Voting) and Employment Rights (Unfair Dismissal) (Amendment) Order 2026 · 15 Jul 2026
- Taxation (Energy and Vehicles) Bill Committee: New Clause 5 · 1 Jul 2026
These Commons divisions share a topic label. The question did not necessarily lead to a vote.
Recorded timeline
21 Feb 2025
Question tabled
To ask the Secretary of State for Health and Social Care, if he will make an (a) economic and (b) regulatory assessment of the potential impact of In Silico computer modelling and simulation methods on the (i) pharmaceutical and (ii) medical device sector
25 Feb 2025
Target answer date
Date supplied by the official written-questions record.
12 Mar 2025
Answer published
Funding has recently been established through the Centre of Excellence in In-Silico Regulatory Science and Innovation (CERSI). This CERSI cements the United Kingdom’s role at the forefront of regulatory science, driving forward the innovations of tomorrow...
Official data retrieved 28 Sept 2026.
Later records
Possible follow-up questions
Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.
Liver Cancer: Medical Treatments
28 Feb 2025 · To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that Chemosat is made available on the NHS following its recommendation by NICE in 2021.
Cancer: Medical Treatments
28 Feb 2025 · To ask the Secretary of State for Health and Social Care, what steps his Department is taking to reduce barriers to NHS funding for (a) Chemosat and (b) other cancer treatments classified as medical devices.
Eye Cancer: Health Services
28 Feb 2025 · To ask the Secretary of State for Health and Social Care, if he will hold discussions with his counterparts in the devolved Administrations on the adequacy of funding for metastatic ocular melanoma patients in each nation.
Rare Cancers: Medical Treatments
28 Feb 2025 · To ask the Secretary of State for Health and Social Care, if he will make an assessment of the (a) potential implications for his policies of the proportion of individual funding request applications for chemosat treatment that are rejected and (b) adequa
Eye Cancer: Medical Treatments
28 Feb 2025 · To ask the Secretary of State for Health and Social Care, what support is available to help patients with metastatic ocular melanoma cope with the psychological impact of limited NHS treatment options.
NHS: Finance
3 Mar 2025 · To ask the Secretary of State for Health and Social Care, what steps he is taking to support (a) the NHS Greater Manchester Integrated Care System and (b) other NHS bodies with (i) financial deficits and (ii) cash flow.
NHS Greater Manchester: Finance
3 Mar 2025 · To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential impact of NHS Greater Manchester's financial deficit on (a) patient care and (b) service delivery.
NHS Greater Manchester: Finance
3 Mar 2025 · To ask the Secretary of State for Health and Social Care, what steps he is taking to help NHS Greater Manchester achieve financial balance by the end of the financial year.
ME/CFS: Research
20 Mar 2025 · To ask the Secretary of State for Health and Social Care, if he will increase funding for biomedical research as part of the cross-Government delivery plan for Myalgic encephalomyelitis.
ME/CFS: Health Services
20 Mar 2025 · To ask the Secretary of State for Health and Social Care, if he will take steps to ensure the delivery plan for myalgic encephalomyelitis will contain mechanisms for (a) scruitnising and (b) measuring progress.
ME/CFS
20 Mar 2025 · To ask the Secretary of State for Health and Social Care, if he will make an assessment of the potential impact of myalgic encephalomyelitis on the economy.
Osteoporosis: Menopause
1 Apr 2025 · To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of carrying out bone density scans for early onset osteoporosis in women who have gone through the menopause.